A new method for assaying the main components of Perftoran formulation based on 1H and 19F NMR spectroscopy was developed. The method was developed for inclusion in the Manufacturer’s Pharmacopeia Article for Perftoran.
Similar content being viewed by others
References
V. P. Sukhorukov, A. A. Ragimov, S. Yu. Pushkin, et al., Perftoran – a Fluorohydrocaron Blood Substituent with Gas Transport Functions, Notes for Doctors [in Russian], Moscow (2012), pp. 3 – 11.
V. A. Ivlev, A. S. Prokop’ev, and G. A. Kalabin, Vestnik RUDN Ser Ékol. Bezopas. Zhiznedeyat., 1, 5 – 14 (2015).
W. R. Dolbier, Jr., Guide to Fluorine NMR for Organic Chemists, John Wiley & Sons, Inc. (2009).
B. M. Fung, Organic Magnetic Resonance, 21, No. 6, 397 – 398 (1983).
Patent RF RU 2263662 C2 (2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 50, No. 4, pp. 52 – 55, April, 2016.
Rights and permissions
About this article
Cite this article
Ivlev, V.A., Kalabin, G.A. & Maslennikov, I.A. Assay of the Composition of Perftoran by NMR Spectroscopy. Pharm Chem J 50, 270–274 (2016). https://doi.org/10.1007/s11094-016-1436-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-016-1436-8